Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAGE4 pseudogene 1 (PAGE4P1) is a human pseudogene corresponding to the PAGE4 gene family. Pseudogenes are nonfunctional copies of genes, usually arising from gene duplication or retrotransposition, and commonly contain sequence disruptions such as frame-shift mutations or premature stop codons that prevent the formation of functional proteins[2][5]. Most pseudogenes were historically thought to be "genomic fossils," but some have been implicated in gene regulation, primarily at the RNA level, through mechanisms like miRNA binding (acting as miRNA decoys or competing endogenous RNAs)[3][4][5]. However, there is no evidence that PAGE4P1 itself encodes a functional transcript, protein, or is involved in human disease or drug action. In summary, PAGE4P1 is not a protein-coding gene, receptor, or therapeutic target; it is a pseudogene with no documented functional or clinical relevance. If you are interested in the functional parental gene or a known target, you may want to refer to "PAGE4 (Prostate associated gene 4)" rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAGE4 pseudogene 1 (PAGE4P1).